place

Belvidere Discount Mall

1965 establishments in IllinoisPages containing links to subscription-only contentShopping malls established in 1965Shopping malls in Lake County, IllinoisWaukegan, Illinois

Belvidere Discount Mall is a small shopping mall located on Belvidere Street in Waukegan, Illinois, United States. It was one of the first shopping malls in the Chicago metropolitan area, and the first enclosed shopping mall in Lake County. Its current main anchor store is a Home Depot. The mall is notable for reinventing itself over time to remain open, with a current store mix.

Excerpt from the Wikipedia article Belvidere Discount Mall (License: CC BY-SA 3.0, Authors).

Belvidere Discount Mall
South Lewis Avenue, Waukegan

Geographical coordinates (GPS) Address Nearby Places
placeShow on map

Wikipedia: Belvidere Discount MallContinue reading on Wikipedia

Geographical coordinates (GPS)

Latitude Longitude
N 42.34927 ° E -87.85859 °
placeShow on map

Address

Belvidere Mall

South Lewis Avenue
60085 Waukegan
Illinois, United States
mapOpen on Google Maps

Share experience

Nearby Places

AbbVie
AbbVie

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked sixth on the list of largest biomedical companies by revenue. In 2023, the company's seat in Forbes Global 2000 was 74, and rank 89 on the 2024 list. The company's primary product is Humira (adalimumab) ($14 billion in 2023 revenues, 27 percent of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohn's disease, plaque psoriasis, and ulcerative colitis. It developed Skyrizi ($7.8 billion in 2023 revenues), an interleukin-23 (IL-23) inhibitor also used to treat autoimmune diseases. Its other major products include Botox ($5.7 billion in 2023 revenues), Imbruvica to treat cancer ($3.6 billion in 2023 revenues), Rinvoq to treat arthritis ($4 billion in 2023 revenues), Venclexta to treat leukemia and lymphoma ($2.3 billion in 2023 revenues), Vraylar to treat schizophrenia and bipolar disorder ($2.7 billion in 2023 revenues), and Mavyret to treat Hepatitis C ($1.4 billion in 2023 revenues).: 39–40  The company is also committed to product development for other treatments of cancer, neurologic diseases, eye care, and cystic fibrosis.: 34  In 2023, Humira began facing competition from a biosimilar developed by Amgen. The company is also developing a drug for Parkinson's disease that could be a blockbuster drug in 2027 and is awaiting approval from the Food and Drug Administration for epcoritamab, a blood-cancer therapy under development in partnership with Genmab. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'.